Literature DB >> 15643979

Dendritic cells, therapeutic vectors of immunity and tolerance.

Damien Chaussabel, Jacques Banchereau.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15643979     DOI: 10.1111/j.1600-6143.2004.00784.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  4 in total

1.  Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo.

Authors:  Ryan T Fischer; Hēth R Turnquist; Zhiliang Wang; Donna Beer-Stolz; Angus W Thomson
Journal:  Transpl Immunol       Date:  2011-05-10       Impact factor: 1.708

2.  Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production.

Authors:  Chang-Hung Chen; Helen Floyd; N Eric Olson; Dario Magaletti; Chang Li; Kevin Draves; Edward A Clark
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

3.  PU.1-silenced dendritic cells prolong allograft survival in rats receiving intestinal transplantation.

Authors:  Xing-Wei Xu; Bo-Wen Ding; Chuan-Rong Zhu; Wu Ji; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

4.  Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation.

Authors:  Camila Macedo; Hēth Turquist; Diana Metes; Angus W Thomson
Journal:  Transplant Res       Date:  2012-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.